Nathan V. Lee

Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

Ping Chen, Nathan V. Lee, Wenyue Hu et al. · Molecular Cancer Therapeutics · 2016 · 422 citations

Medicine, Oncology, Pharmacology +9

Endocardial Brg1 Represses ADAMTS1 to Maintain the Microenvironment for Myocardial Morphogenesis

Kryn Stankunas, Calvin T. Hang, Zhi-Yang Tsun et al. · Developmental Cell · 2008 · 256 citations · Full text

Life Sciences, Biology, Molecular Biology +12

ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2

Nathan V. Lee, Makoto Sato, Douglas S. Annis et al. · The EMBO Journal · 2006 · 207 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +5

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Nicole R. Infarinato, Jin H. Park, Kateryna Krytska et al. · Cancer Discovery · 2015 · 181 citations · Full text

Medicine, Oncology, Pharmacology +15

Fibulin-1 Acts as a Cofactor for the Matrix Metalloprotease ADAMTS-1

Nathan V. Lee, Juan Carlos Rodrı́guez-Manzaneque, Shelley N.-M. Thai et al. · Journal of Biological Chemistry · 2005 · 103 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14